Insulet Corporation (PODD) PT Raised to $303 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Insulet Corporation (PODD) PT Raised to $295 at Stifel
November 5, 2021 6:43 AM EDTStifel analyst Matthew Blackman raised the price target on Insulet Corporation (NASDAQ: PODD) to $295.00 (from $275.00) while maintaining a Hold rating.
The analyst commented, "PODD 3Q results were largely in-line with Consensus despite US Covid headwinds and intensifying OUS competitive pressures. WW Sales grew... More
